Acurx Pharmaceuticals (ACXP) Short Interest Ratio & Short Volume $0.82 +0.07 (+8.77%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Acurx Pharmaceuticals Short Interest DataAcurx Pharmaceuticals (ACXP) has a short interest of 463,900 shares, representing 3.22% of the float (the number of shares available for trading by the public). This marks a 4.55% increase in short interest from the previous month. The short interest ratio (days to cover) is 4.1, indicating that it would take 4.1 days of the average trading volume of 107,628 shares to cover all short positions.Current Short Interest463,900 sharesPrevious Short Interest443,700 sharesChange Vs. Previous Month+4.55%Dollar Volume Sold Short$579,875.00Short Interest Ratio4.1 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares16,893,000 sharesFloat Size14,390,000 sharesShort Percent of Float3.22%Today's Trading Volume100,693 sharesAverage Trading Volume107,628 sharesToday's Volume Vs. Average94% Short Selling Acurx Pharmaceuticals? Sign up to receive the latest short interest report for Acurx Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartACXP Short Interest Over TimeACXP Days to Cover Over TimeACXP Percentage of Float Shorted Over Time Ad Brownstone ResearchCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.Click here to see the details because I believe a lot of people will get rich. Acurx Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/2024463,900 shares $579,875.00 +4.6%3.2%4.1 $1.25 11/15/2024443,700 shares $763,164.00 -6.5%3.1%5.9 $1.72 10/31/2024474,500 shares $892,060.00 -5.5%3.4%10.1 $1.88 10/15/2024501,900 shares $1.02 million +2.1%3.6%10.2 $2.04 9/30/2024491,700 shares $934,230.00 +2.8%3.6%7.6 $1.90 9/15/2024478,300 shares $975,732.00 +5.6%3.5%7.8 $2.04 Get the Latest News and Ratings for ACXP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acurx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/31/2024452,800 shares $996,160.00 +3.1%3.3%7.7 $2.20 8/15/2024439,400 shares $896,376.00 -5.4%3.2%8.1 $2.04 7/31/2024464,300 shares $1.00 million -17.3%3.5%7.8 $2.16 7/15/2024561,200 shares $1.34 million -8.6%4.2%9.4 $2.39 6/30/2024614,100 shares $1.38 million -7.1%4.6%10.9 $2.25 6/15/2024661,200 shares $1.61 million -4.0%4.9%10.6 $2.43 5/31/2024688,400 shares $1.73 million +15.6%5.1%9.2 $2.51 5/15/2024595,600 shares $1.34 million -3.2%4.4%7.4 $2.25 4/30/2024615,500 shares $1.38 million +6.3%4.7%7.4 $2.25 4/15/2024579,100 shares $946,828.50 +71.6%4.8%5.6 $1.64 3/31/2024337,400 shares $826,630.00 +14.6%2.8%2 $2.45 3/15/2024294,500 shares $801,040.00 +0.9%2.5%1.7 $2.72 2/29/2024291,900 shares $837,753.00 -3.2%2.6%1.3 $2.87 2/15/2024301,500 shares $919,575.00 -12.3%2.7%1.3 $3.05 1/31/2024343,700 shares $1.12 million +41.1%3.0%1.4 $3.27 1/15/2024243,600 shares $1.13 million -18.5%2.1%0.7 $4.63 12/31/2023298,800 shares $1.14 million -32.0%2.6%0.5 $3.83 12/15/2023439,100 shares $1.54 million -21.0%3.9%0.5 $3.50 11/30/2023555,800 shares $1.96 million -14.3%5.0%0.7 $3.52 11/15/2023648,300 shares $2.23 million -31.5%5.8%0.9 $3.44 10/31/2023946,100 shares $5.06 million -9.0%9.0%1.3 $5.35 10/15/20231,040,000 shares $4.51 million +10,197.0%9.9%1.6 $4.34 9/30/202310,100 shares $15,150.00 +50.8%0.1%0 $1.50 9/15/20236,700 shares $11,859.00 -51.1%0.1%0.2 $1.77 8/31/202313,700 shares $26,441.00 +95.7%0.1%0.4 $1.93 8/15/20237,000 shares $11,200.00 -63.0%0.1%0.2 $1.60 7/31/202318,900 shares $38,367.00 +42.1%0.2%0.7 $2.03 7/15/202313,300 shares $28,462.00 +58.3%0.1%0.5 $2.14 6/30/20238,400 shares $22,260.00 -27.6%0.1%0.3 $2.65 6/15/202311,600 shares $31,900.00 +39.8%0.1%0.5 $2.75 5/31/20238,300 shares $25,730.00 -60.9%0.1%0.3 $3.10 5/15/202321,200 shares $71,868.00 -7.0%0.2%0.7 $3.39 4/30/202322,800 shares $68,172.00 +4.1%0.3%0.7 $2.99 4/15/202321,900 shares $64,824.00 -25.5%0.2%0.7 $2.96Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. 3/31/202329,400 shares $101,724.00 -52.8%0.3%0.9 $3.46 3/15/202362,300 shares $212,443.00 +150.2%0.7%1.8 $3.41 2/28/202324,900 shares $82,419.00 -33.8%0.3%0.7 $3.31 2/15/202337,600 shares $131,976.00 +78.2%0.4%1.2 $3.51 1/31/202321,100 shares $75,960.00 -7.9%0.2%0.7 $3.60 1/15/202322,900 shares $97,325.00 -3.4%0.2%0.9 $4.25 12/30/202223,700 shares $94,326.00 -18.0%0.3%1 $3.98 12/15/202228,900 shares $112,710.00 +26.8%0.3%1.4 $3.90 11/30/202222,800 shares $72,732.00 -1.3%0.2%1 $3.19 11/15/202223,100 shares $72,072.00 +5.5%0.3%1 $3.12 10/31/202221,900 shares $67,452.00 -27.2%0.2%0.8 $3.08 10/15/202230,100 shares $88,795.00 -22.2%0.3%1.1 $2.95 9/30/202238,700 shares $116,100.00 +45.5%0.4%1.5 $3.00 9/15/202226,600 shares $103,740.00 +10.8%0.3%1 $3.90 8/31/202224,000 shares $83,760.00 -34.1%0.3%0.9 $3.49 8/15/202236,400 shares $164,164.00 -13.5%0.4%1.6 $4.51 7/31/202242,100 shares $150,718.00 +89.6%0.5%2.1 $3.58 7/15/202222,200 shares $80,475.00 -43.9%N/A1.4 $3.63 6/30/202239,600 shares $150,084.00 -29.9%N/A2.5 $3.79 6/15/202256,500 shares $213,570.00 +16.3%N/A3.2 $3.78 5/31/202248,600 shares $130,734.00 -1.2%N/A2.8 $2.69 5/15/202249,200 shares $133,332.00 +39.4%N/A2.7 $2.71 4/30/202235,300 shares $131,669.00 -59.2%N/A2 $3.73 4/15/202286,600 shares $346,400.00 -22.3%N/A3.3 $4.00 3/31/2022111,400 shares $365,392.00 +136.5%N/A4 $3.28 3/15/202247,100 shares $175,683.00 +9.0%N/A1.6 $3.73 2/28/202243,200 shares $157,209.12 -53.7%N/A1.4 $3.64 2/15/202293,300 shares $375,999.00 -4.3%N/A2.6 $4.03 1/31/202297,500 shares $405,600.00 -28.8%N/A2.3 $4.16 1/15/2022137,000 shares $627,460.00 -16.2%N/A3 $4.58 12/31/2021163,400 shares $706,116.76 -6.0%N/A3.6 $4.32 12/15/2021173,800 shares $716,056.00 +52.2%N/A2.9 $4.12 11/30/2021114,200 shares $548,160.00 -17.1%N/A1.9 $4.80 11/15/2021137,700 shares $684,369.00 +14.9%N/A2.2 $4.97 10/29/2021119,800 shares $599,000.00 +17.7%N/A1.7 $5.00 10/15/2021101,800 shares $499,838.00 -4.9%N/A1.2 $4.91 9/30/2021107,000 shares $549,980.00 +11.2%N/A0.8 $5.14 9/15/202196,200 shares $485,810.00 +24.9%N/A0.2 $5.05 8/31/202177,000 shares $398,090.00 -35.9%N/A0.1 $5.17 8/13/2021120,100 shares $576,480.00 No ChangeN/A0.1 $4.80 ACXP Short Interest - Frequently Asked Questions What is Acurx Pharmaceuticals' current short interest? Short interest is the volume of Acurx Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of November 30th, investors have sold 463,900 shares of ACXP short. 3.22% of Acurx Pharmaceuticals' shares are currently sold short. Learn More on Acurx Pharmaceuticals' current short interest. What is a good short interest ratio for Acurx Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ACXP shares currently have a short interest ratio of 4.0. Learn More on Acurx Pharmaceuticals's short interest ratio. What is a good short interest percentage for Acurx Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.22% of Acurx Pharmaceuticals' floating shares are currently sold short. Is Acurx Pharmaceuticals' short interest increasing or decreasing? Acurx Pharmaceuticals saw a increase in short interest during the month of November. As of November 30th, there was short interest totaling 463,900 shares, an increase of 4.6% from the previous total of 443,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Acurx Pharmaceuticals' float size? Acurx Pharmaceuticals currently has issued a total of 16,893,000 shares. Some of Acurx Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Acurx Pharmaceuticals currently has a public float of 14,390,000 shares. How does Acurx Pharmaceuticals' short interest compare to its competitors? 3.22% of Acurx Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Acurx Pharmaceuticals: Janone Inc. (0.61%), Immuneering Co. (7.37%), Shattuck Labs, Inc. (5.09%), Iterum Therapeutics plc (9.47%), AlloVir, Inc. (1.66%), IO Biotech, Inc. (0.10%), Celularity Inc. (6.44%), Omega Therapeutics, Inc. (29.53%), vTv Therapeutics Inc. (1.61%), Aileron Therapeutics, Inc. (0.92%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Acurx Pharmaceuticals stock? Short selling ACXP is an investing strategy that aims to generate trading profit from Acurx Pharmaceuticals as its price is falling. ACXP shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Acurx Pharmaceuticals? A short squeeze for Acurx Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ACXP, which in turn drives the price of the stock up even further. How often is Acurx Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ACXP, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies Janone Short Interest Immuneering Short Interest Shattuck Labs Short Interest Iterum Therapeutics Short Interest AlloVir Short Interest IO Biotech Short Interest Celularity Short Interest Omega Therapeutics Short Interest vTv Therapeutics Short Interest Aileron Therapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ACXP) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acurx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acurx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ACXP Stock Alerts